Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
{{output}}
Introduction: Type 2 diabetes is increasing in prevalence worldwide and is a leading cause of morbidity and mortality, mainly due to the development of complications. Vildagliptin is an inhibitor of dipeptidyl peptidase 4 (DPP-4)... ...
